Category Archives: Non Small Cell Lung Cancer

It is Better for Cancer Patients to Die at Home

Posted on November 14, 2010 by wngai

Cancer patients who die at home do so more peacefully and their caregivers also end up doing better emotionally, reported in the September 13th issue in the Journal of Clinical Oncology  Wright’s team studied 342 terminal cancer patients and their … Continue reading →

Posted in Acute Promyelocytic Leukemia, Breast cancer, Cancer, Colorectal cancer, Esophageal Cancer, Gallbladder cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Nasopharyngeal Cancer, Non Small Cell Lung Cancer, Non-Hodgkin's Disease, Ovarian Cancer, Pancreatic Cancer, Prostate cancer, Small Cell Lung Cancer | Tagged , , , , , | Comments Off on It is Better for Cancer Patients to Die at Home

First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

Posted on October 16, 2010 by wngai

First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading →

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations

Posted on July 25, 2010 by wngai

Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations.  The current study was conducted in 230 patients from 43 centers in Japan, … Continue reading →

Posted in Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , | Comments Off on Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations

Is Shark Cartilage Helpful For Cancer Patients?

Posted on June 26, 2010 by wngai

Shark cartilage has been touted as a potential alternative or complementary cancer treatment for several decades. Dozens of shark cartilage products are sold as dietary supplements, but none have been studied in humans. A recently published study indicated that adding a … Continue reading →

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer, Tea | Tagged , , , , , , | Comments Off on Is Shark Cartilage Helpful For Cancer Patients?

Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

Posted on April 25, 2010 by wngai

Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC.  However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading →

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , | Comments Off on Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)